Director, Clinical Science – Oncology Clinical Development

GSK plc; Greater London; Hybrid; GBP 150,000 - 190,000; Full time

Benefits offered by this job

Annual bonus

Share-based long term incentive

Health care and family insurance

Retirement benefits

Paid holidays

Vacation

Paid caregiver/parental and medical-le

Job summary

GSK plc is seeking a Director, Clinical Science – Oncology to provide scientific leadership across defined components of study design, data review and interpretation within the Clinical Development Plan. This role requires deep oncology expertise, strong collaboration, and the ability to operate in a complex matrix environment.

The position is hybrid with on‑site presence at Stevenage and potential relocation to Cambridge by early 2029.

Qualifications

• Bachelor’s degree in life sciences or related discipline required.
• 5+ years of experience in pharmaceutical/bi biotechnology clinical development with oncology focus.
• Experience in clinical development from early stage through regulatory submission and data review.

Responsibilities

• Provide scientific leadership across study design, data review and interpretation within CDL direction.
• Serve as core member of Clinical Matrix Team ensuring alignment of objectives and timelines.
• Contribute to asset-level strategy, benefit–risk assessment and programme decisions.
• Ensure quality and consistency of protocols and CSRs and submission materials.
• Analyze and interpret data to inform safety, efficacy and patient populations.
• Engage with investigators and external experts to support study execution and scientific exchange.

Skills

Analytical thinking

Leadership

Clinical development

Cross-functional collaboration

Data interpretation

Education

Bachelor’s degree in life sciences or related discipline

Advanced degree (MS/PhD) preferred

Job description

For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge, UK in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029.

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting‑edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together.

Our approach to R&D

Overview

Cancer is unrelenting, but so are we. At GSK, we are committed to transforming outcomes for people with cancer through innovative science, bold ambition, and strong partnerships across the healthcare ecosystem. We focus our science where it can matter most—advancing care in cancers with high unmet need, grounded in a deep understanding of disease biology and deliberate scientific choices that connect discovery to meaningful impact in the real world.

The Director, Clinical Science – Oncology Clinical Development provides scientific leadership across defined components of study design, conduct, data review, and interpretation within an assigned clinical programme. Reporting to the Clinical Development Lead (CDL), this role operates within the asset‑level clinical strategy and contributes scientific depth and rigour to the execution of the Clinical Development Plan (CDP).

The Director, Clinical Scientist partners closely with the Senior Scientist and cross‑functional teams to support delivery of clinical studies, ensuring scientific quality, data integrity, and robust interpretation of clinical data. This role contributes to both study‑level activities and broader programme insights, without holding accountability for asset‑level strategy or overall study delivery.

This is a scientific individual contributor role requiring deep oncology clinical development expertise, strong analytical and collaboration skills, and the ability to operate effectively within a complex, matrixed environment.

In This Role You Will:

• Provide scientific leadership across defined components of study-level activities, including protocol development, study design, data review, and interpretation, within the strategic direction set by the CDL
• Serve as a core member of the Clinical Matrix Team (CMT), ensuring scientific alignment across study objectives, timelines, and deliverables
• Provide scientific insight to the CDL and Senior Scientist to inform asset‑level strategy, benefit–risk assessment, and programme‑level decision‑making
• Ensure the scientific quality and consistency of key clinical and regulatory documents, including protocols, Investigator’s Brochures, Clinical Study Reports, and submission materials
• Apply scientific and clinical expertise to analyse and interpret data, ensuring rigour, integrity, and relevance to the target patient population
• Engage with internal and external stakeholders, including investigators and Key External Experts, to support study execution and scientific exchange
• Contribute to a culture of scientific excellence, innovation, and continuous improvement within Oncology Clinical Development

Detailed Responsibilities:

Study Design and Execution

• Provide scientific input into protocol development and study design, ensuring robustness, feasibility, and alignment with CDP‑defined objectives and regulatory requirements
• Author or co‑author key study documents (e.g., Clinical Study Proposals), contributing to preparation and presentation at governance forums such as Protocol Review Boards
• Support study conduct by addressing scientific questions, ensuring data integrity, and maintaining alignment with protocol and regulatory standards
• Provide scientific input into study‑level decisions related to protocol implementation and study conduct, within the strategic framework defined by the CDL
• Present and support the scientific rationale and study design at Investigator Meetings and respond to scientific inquiries from study sites
• Support implementation of study‑level Go/No‑Go criteria aligned to the asset‑level decision framework defined by the CDL

Data Generation, Analysis, and Interpretation

• Analyse and interpret clinical data to generate insights on safety, efficacy, and patient populations
• Integrate data from internal and external sources (e.g., literature, competitor data, emerging science) to inform study and programme understanding
• Provide scientific input into data review and interpretation activities, in collaboration with Medical Directors and pharmacovigilance
• Translate study findings into clear scientific insights to inform programme progression and support CDL‑led decision‑making

Clinical and Regulatory Deliverables

• Contribute to development of clinical and regulatory documents, including protocols, Investigator’s Brochures (IBs), Clinical Study Reports (CSRs), and submission materials
• Ensure scientific accuracy, consistency, and quality across study documentation
• Support preparation of regulatory submissions and responses to Health Authority queries
• Contribute to regulatory reporting requirements (e.g., DSURs, INDSRs) and ensure alignment with regulatory standards

Cross‑Functional Collaboration & Scientific Contribution

• Serve as a core member of the CMT, partnering with Clinical Operations, Statistics, Safety, Regulatory, and Medical Affairs to support integrated study delivery
• Provide scientific expertise to cross‑functional discussions, including integrated evidence planning and disease‑area forums, as appropriate
• Participate in internal and external scientific interactions with investigators, Key External Experts, advisory boards, and collaborators
• Contribute to scientific communications, including publications, congress presentations, and study‑related materials

Ways of Working & Continuous Improvement

• Identify scientific and operational risks at the study level and provide input into mitigation strategies
• Support and drive implementation of consistent ways of working and process improvements across the programme
• Participate in Oncology Clinical Development initiatives and workstreams to strengthen standards, processes, and capabilities
• Engage in ongoing development to deepen scientific expertise, expand disease‑area knowledge, and build broader clinical development capabilities

Why You?

Working model: This role is hybrid. You will be on‑site at one of the posted locations at least two days per week. Remote work is available on other days.

Basic Qualifications

• Bachelor’s degree in life sciences or related scientific discipline required
• 5+ years of experience in pharmaceutical/biotechnology industry or related clinical development experience, with a focus on oncology.
• Experience in clinical development from early stage through to regulatory submission, including study design, protocol authoring, and data review/interpretation.
• Experience working within GCP, ICH, and global regulatory guidelines.
• Experience authoring or contributing to clinical study proposals, protocols, Investigator’s Brochures, informed consent forms, clinical study reports, and regulatory submissions.
• Experience working within cross‑functional matrix teams and contributing to clinical decision‑making.
• Proven track record of working with investigators, site staff, external experts, CROs, and vendors.

Preferred Qualifications

• Advanced degree (e.g. MS, PhD, PharmD) strongly preferred in life sciences or a related discipline
• Clinical development experience across multiple phases of development (Phase I–IV)
• Oncology or immuno‑oncology clinical development experience.
• Experience presenting or preparing materials for Protocol Review Boards, governance meetings, or scientific forums.
• Knowledge of regulatory requirements to support registration, including experience contributing to IND, EoP2, scientific advice, pre‑NDA/BLA, NDA/MAA, or AdCom submissions.

What we value

We act with transparency, respect and integrity. We welcome different perspectives and champion inclusion. Bring curiosity, humility and a clear focus on patients.

Skills

• Analytical Thinking
• Business Acumen
• Change Management
• Clinical Research
• Clinical Trial Designs
• Communication
• Decision Making
• Fostering Collaboration
• Influencing Without Authority
• Leadership
• Matrix Leadership
• Mentorship
• People Management
• Risk Management
• Strategic Thinking

If you are based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges $189,750 to $316,250. The US salary ranges take into account a number of factors including work location within the US market, the candidate’s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share based long term incentive program which is dependent on the level of the role.

Benefits

• annual bonus
• eligibility to participate in our share based long term incentive program which is dependent on the level of the role
• health care and other insurance benefits (for employee and family)
• retirement benefits
• paid holidays
• vacation
• paid caregiver/parental and medical leave

Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

If you require an accommodation or other assistance to apply for a job at GSK, please contact the appropriate Recruitment Staff by emailing us at [e-mail].

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

We appreciate that medical benefits coverage may vary by location, and we encourage you to review the benefits information provided within the GSK Benefits program. Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements.

For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at https://openpaymentsdata.cms.gov/.